Cargando…
Targeting Mutated p53: Naivete and Enthusiasm to Attempt the Impossible
Tumor suppressor TP53 is an important gene in human cancer because it is mutated in the majority of tumors, leading to loss-of-function or gain-of-function phenotypes. Mutated TP53 acts like an oncogene, driving cancer progression and causing poor patient outcomes. The role of mutated p53 in cancer...
Autor principal: | El-Deiry, Wafik S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071817/ https://www.ncbi.nlm.nih.gov/pubmed/37014041 http://dx.doi.org/10.1158/0008-5472.CAN-22-0995 |
Ejemplares similares
-
Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research
por: Levine, Arnold J.
Publicado: (2022) -
Addressing Common Misuses and Pitfalls of P values in Biomedical Research
por: Wang, Ming, et al.
Publicado: (2022) -
Dual Recombinase–Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy
por: Sket, Tina, et al.
Publicado: (2023) -
Are There Specific Cancer Stem Cell Markers?
por: Lan, Linxiang, et al.
Publicado: (2023) -
Translating “Big Data” in Oncology for Clinical Benefit: Progress or Paralysis
por: Barker, Anna D., et al.
Publicado: (2022)